Q2 2025
Quarter Ended Jun 30, 2025
IDSA Clinical Infectious Diseases; Emergence and spread of Clostridioides difficile Isolates with Reduced Fidaxomicin Susceptibility in an Acute Care Hospital
View the latest financials